The store will not work correctly when cookies are disabled.
N-(3-(2-Amino-5-methoxyphenyl)-3-oxopropyl)benzimidamide
ID: ALA4877396
PubChem CID: 164627059
Max Phase: Preclinical
Molecular Formula: C17H19N3O2
Molecular Weight: 297.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(N)c(C(=O)CCNC(=N)c2ccccc2)c1
Standard InChI: InChI=1S/C17H19N3O2/c1-22-13-7-8-15(18)14(11-13)16(21)9-10-20-17(19)12-5-3-2-4-6-12/h2-8,11H,9-10,18H2,1H3,(H2,19,20)
Standard InChI Key: POOQEWHBMDFPST-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
21.1717 -11.3134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1630 -10.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8831 -11.7150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4691 -11.7289 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7578 -11.3274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0552 -11.7429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0598 -12.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7752 -12.9616 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3572 -12.9797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3659 -13.7968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6633 -14.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9519 -13.8108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9432 -12.9937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6458 -12.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0772 -14.1943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2343 -12.5914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5309 -13.0074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8673 -10.0811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8590 -9.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1464 -8.8629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4408 -9.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4527 -10.0984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 1 0
7 8 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
10 15 1 0
7 9 1 0
4 5 1 0
16 17 1 0
13 16 1 0
2 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 2 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 297.36 | Molecular Weight (Monoisotopic): 297.1477 | AlogP: 2.47 | #Rotatable Bonds: 6 |
Polar Surface Area: 88.20 | Molecular Species: BASE | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 11.23 | CX LogP: 2.30 | CX LogD: -0.10 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.33 | Np Likeness Score: -0.43 |
References
1. Arias F, Franco-Montalban F, Romero M, Carrión MD, Camacho ME.. (2021) Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors., 44 [PMID:34218000] [10.1016/j.bmc.2021.116294] |